<p><b>Now with a new afterword covering the months-long landmark trials of Elizabeth Holmes and Sunny Balwani.</b><br><br><b>‘I couldn’t put down this thriller . . . the perfect book to read by the fire this winter.’ Bill Gates</b><br><br><b>Winner of the Financial Times/McKinsey Business Book of the Year Award 2018</b><br><br>The riveting true story of the breathtaking rise and shocking collapse of Theranos, the multibillion-dollar biotech startup founded by Elizabeth Holmes, by the prize-winning journalist who first broke the story and pursued it to the end, despite pressure from its charismatic CEO and threats by her lawyers.<br><br>In 2014, Theranos founder and CEO Elizabeth Holmes was widely seen as the female Steve Jobs: a brilliant Stanford dropout whose startup ‘unicorn’ promised to revolutionize the medical industry with a machine that would make blood testing significantly faster and easier. Backed by investors such as Larry Ellison and Tim Draper, Theranos sold shares in a fundraising round that valued the company at more than $9 billion, putting Holmes’s worth at an estimated $4.7 billion. There was just one problem: the technology didn’t work.<br><br>In <i>Bad Blood</i>, John Carreyrou tells the riveting story of the biggest corporate fraud since Enron, a tale of ambition and hubris set amid the bold promises of Silicon Valley.<br><br><b>‘Chilling . . . Reads like a West Coast version of <i>All the President’s Men</i>.’ <i>New York Times Book Review</i></b></p>